Pages that link to "Q73472549"
Jump to navigation
Jump to search
The following pages link to SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts (Q73472549):
Displaying 10 items.
- Hypothermic preconditioning induces rapid tolerance to focal ischemic injury in the rat. (Q30310894) (← links)
- Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology (Q33972677) (← links)
- Kinases as therapeutic targets for heart failure (Q35058555) (← links)
- Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology (Q35169365) (← links)
- Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure (Q37284634) (← links)
- Role of p38 inhibition in cardiac ischemia/reperfusion injury (Q37972088) (← links)
- Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury (Q41995901) (← links)
- Delayed neuroprotection induced by sevoflurane via opening mitochondrial ATP-sensitive potassium channels and p38 MAPK phosphorylation (Q48250542) (← links)
- Disruption of a single copy of the p38alpha MAP kinase gene leads to cardioprotection against ischemia-reperfusion. (Q52549405) (← links)
- Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia-reperfusion injury (Q61449103) (← links)